Results 1 to 10 of about 34,804 (275)

Sublingual immunotherapy: administration, dosages, use [PDF]

open access: yesInternational journal of immunopathology and pharmacology, 2009
Allergen extracts for sublingual immunotherapy (SLIT) are currently marketed by several manufacturers, with administration schedules and amount of allergen(s) quite variable in the different products, although almost all are standardized biologically or ...
Bernardini, R   +7 more
core   +5 more sources

Tinnitus after administration of sublingual immunotherapy [PDF]

open access: yesSAGE Open Medical Case Reports, 2017
Background/objectives: Sublingual immunotherapy was first described in 1986. Since then, its use has been increased as an alternative to subcutaneously administered immunotherapy in the treatment of allergic rhinitis.
Jacob Juel
doaj   +3 more sources

Expanding the therapeutic landscape of minoxidil for androgenetic alopecia: topical, oral and sublingual formulations [PDF]

open access: yesFrontiers in Pharmacology
Androgenetic alopecia (AGA) is the most common form of non-scarring alopecia, affecting up to 80% of men and 50% of women by the age of 70. Minoxidil, initially developed as an oral antihypertensive, has become one of the most widely used therapies for ...
Flavia Rodrigues Dias   +5 more
doaj   +2 more sources

Efficacy of sublingual and oral vitamin B12 versus intramuscular administration: insights from a systematic review and meta-analysis [PDF]

open access: yesFrontiers in Pharmacology
BackgroundVitamin B12 deficiency is a widespread condition, particularly among elderly individuals, patients with malabsorption syndromes, and those following plant-based diets.
Marta Mazur   +12 more
doaj   +2 more sources

Correlations Between Rheology, In Situ Mucosal Retention and In Vivo Immunogenicity Reveal the Potential and Limitations of Mucoadhesive Excipients for Sublingual Vaccine Delivery [PDF]

open access: yesPharmaceutics
Background/Objectives: Sublingual vaccination offers a non-invasive route for inducing both systemic and mucosal immunity, yet the formulation properties that govern its success remain poorly defined.
Mohamed Deifallah Yousif   +3 more
doaj   +2 more sources

Sublingual vs. vaginal misoprostol for cervical preparation before surgical abortion in the first trimester [PDF]

open access: yesNew Indian Journal of OBGYN, 2023
Background: Suction evacuation is the most common surgical method of first-trimester pregnancy termination and cervical dilatation is the most critical step.
Neeru Malik   +5 more
doaj   +1 more source

Development of Sedative Dexmedetomidine Sublingual In Situ Gels: In Vitro and In Vivo Evaluations

open access: yesPharmaceutics, 2022
Intravenous dexmedetomidine (DEX) is currently approved by the FDA for the sedation of intubated patients in intensive care units to reduce anxiety and to augment postoperative analgesia.
Ayat A. Allam   +10 more
doaj   +1 more source

Comparative study of sublingual versus vaginal misoprostol following mifepristone in early first trimester medical termination of pregnancy - a prospective study [PDF]

open access: yesNew Indian Journal of OBGYN, 2019
Aim: To compare the efficacy and side effects of sublingual versus vaginal administration of misoprostol after a single oral dose of 200 mg of mifepristone in termination of early first trimester pregnancy. Methods: This is a randomised prospective study
B. L Pathak, Shikha Hajong Roy
doaj   +1 more source

Ephedrine vs. phenylephrine effect on sublingual microcirculation in elderly patients undergoing laparoscopic rectal cancer surgery

open access: yesFrontiers in Medicine, 2022
BackgroundThe effects of anesthesia administration on sublingual microcirculation are unknown. It is unclear how sublingual microcirculation responds to ephedrine or phenylephrine administration.
Yanbing Zhang   +4 more
doaj   +1 more source

A Randomized, Double-Blinded, Placebo-Controlled, Cross Over Study Evaluating the Efficacy and Safety of Timolol Ophthalmic Solution as an Acute Treatment of Migraine [PDF]

open access: yes, 2020
Introduction. Daily oral beta-adrenoreceptor antagonist has been shown to be effective in preventing migraine headaches. Timolol 0.5% ophthalmic solution is a non-selective beta-adrenoreceptor antago- nist, where the primary use is for glaucoma.
Aggarwal, Dipika   +10 more
core   +2 more sources

Home - About - Disclaimer - Privacy